 |
|
Einstein scientists discover cause and possible treatments for hereditary movement disorder
March 02, 2006Researchers at the Albert Einstein College of Medicine of Yeshiva University have discovered the underlying cause of a type of ataxia, hereditary disorders characterized by poor balance, loss of posture and difficulty performing rapid coordinated movement. Their work also led to a drug that significantly improved the motor coordination in mice with ataxia-a finding that could lead to better therapies for the disease. The study appears in the March issue of Nature Neuroscience and was featured in the publication's advance online edition.
The research, led by Dr. Kamran Khodakhah, associate professor in the department of neuroscience at Einstein, focused on a type of ataxia called episodic ataxia type-2. It results from gene mutations that affect calcium channels, which are involved in releasing neurotransmitters in the brain and regulating excitability in neurons. Episodic ataxia type-2 was thought to be due to impaired transmission of neurotransmitters, but the Einstein scientists suspected that something else was going on.
They studied specialized cells in the brain's cerebellum called Purkinje cells, which are rich in calcium channels. Purkinje cells help coordinate movement by acting as information clearinghouses: They take in sensory and other inputs relayed to them by more than 150,000 excitatory and inhibitory synaptic inputs, combine them with the cello's own intrinsic activity or "pacemaking," and then send out the signals necessary for motor coordination.
The researchers investigated whether ataxia might be due to a reduction in the precision of the intrinsic pacemaking by Purkinje cells. Studying a number of mouse models of ataxia type-2, they found a gene-dependent loss of the precision of pacemaking in Purkinje cells, which prevented them from accurately accounting for the strength and timing of synaptic inputs when sending out signals directing muscle movement.
This loss of pacemaking precision was traced to reduced activity of calcium-activated potassium channels in Purkinje cells - a direct consequence of the reduced activity of calcium channels in these disorders. Einstein researchers were able to remedy this problem with a drug called 1-ethyl-2-benzimidazolinone (EBIO). When EBIO was infused into the brains of ataxic mice, the mice's motor coordination improved significantly.
"These calcium-activated potassium channels proved to be a potent therapeutic target, since chronically activating them with EBIO definitely improved the motor performance of these ataxic mice," says Dr. Khodakhah, who was senior author of the study. "We don't really have effective treatments for these types of ataxia, so we're hopeful that our findings will lead to drugs that will improve the lives of people with this condition."
Dr Khodakhah has established collaborations with two neurologists, Dr Joanna Jen (UCLA) and Dr Michael Strupp (Germany) to explore the potential use of similar drugs in patients. The other Einstein researchers involved in the study were Joy T. Walter, Karina Alvina, Mary D. Womack and Carolyn Chevez.
Albert Einstein College of Medicine
The researchers investigated whether ataxia might be due to a reduction in the precision of the intrinsic pacemaking by Purkinje cells. Studying a number of mouse models of ataxia type-2, they found a gene-dependent loss of the precision of pacemaking in Purkinje cells, which prevented them from accurately accounting for the strength and timing of synaptic inputs when sending out signals directing muscle movement.
This loss of pacemaking precision was traced to reduced activity of calcium-activated potassium channels in Purkinje cells - a direct consequence of the reduced activity of calcium channels in these disorders. Einstein researchers were able to remedy this problem with a drug called 1-ethyl-2-benzimidazolinone (EBIO). When EBIO was infused into the brains of ataxic mice, the mice's motor coordination improved significantly.
"These calcium-activated potassium channels proved to be a potent therapeutic target, since chronically activating them with EBIO definitely improved the motor performance of these ataxic mice," says Dr. Khodakhah, who was senior author of the study. "We don't really have effective treatments for these types of ataxia, so we're hopeful that our findings will lead to drugs that will improve the lives of people with this condition."
Dr Khodakhah has established collaborations with two neurologists, Dr Joanna Jen (UCLA) and Dr Michael Strupp (Germany) to explore the potential use of similar drugs in patients. The other Einstein researchers involved in the study were Joy T. Walter, Karina Alvina, Mary D. Womack and Carolyn Chevez.
Albert Einstein College of Medicine
Ataxia Current Events and Ataxia News RSSTrembling hands and molecular handshakes
Fragile X tremor/ataxia syndrome (FXTAS) is a recently recognized condition, which is actually one of the most prevalent heritable neurodegenerative diseases.
BUSM researchers identify better laser for treating facial spider veins
Researchers from Boston University School of Medicine (BUSM) have concluded that the 940nm wavelength laser is superior for treating facial spider veins (telangiectasias) as compared to the 532nm wavelength laser.
Mechanism for potential Friedreich's ataxia drug uncovered
Using clever chemistry, a Scripps Research team has pinpointed the enzyme target of a drug group that stops the progression of the devastating disease Friedreich's ataxia in mice and may do the same for humans.
Mutations in gene linked to ciliopathies
An international team of scientists, led by researchers at the University of California, San Diego School of Medicine, have discovered a connection between mutations in the INPP5E gene and ciliopathies.
Scientists track impact of DNA damage in the developing brain
Switching off a key DNA repair system in the developing nervous system is linked to smaller brain size as well as problems in brain structures vital to movement, memory and emotion.
Stress signals link pre-existing sickness with susceptibility to bacterial infection
Mitochondrial diseases disrupt the power generating machinery within cells and increase a person's susceptibility to bacterial infection, particularly in the lungs or respiratory tract.
Small molecules might block mutant protein production in Huntington's disease
Molecules that selectively interfere with protein production can stop human cells from making the abnormal molecules that cause Huntington's disease, researchers at UT Southwestern Medical Center have found.
LSUHSC research shows fish oil protects against diseases like Parkinson's
Dr. Nicolas Bazan, Director of the Neuroscience Center of Excellence, Boyd Professor, and Ernest C. and Yvette C. Villere Chair of Retinal Degenerative Diseases Research at LSU Health Sciences Center New Orleans, will present new research findings showing that an omega three fatty acid in the diet protects brain cells by preventing the misfolding of a protein resulting from a gene mutation in neurodegenerative diseases like Parkinson's and Huntington's.
Search for blood pressure secrets reveals a surprising new syndrome
Yale researchers investigating the genetic causes of blood pressure variation have identified a previously undescribed syndrome associated with seizures, a lack of coordination, developmental delay and hearing loss.
U-M researchers ID gene involved in pancreatic cancer
Researchers from the University of Michigan Comprehensive Cancer Center have identified a gene that is overexpressed in 90 percent of pancreatic cancers, the most deadly type of cancer.
More Ataxia Current Events and Ataxia News Articles
 |
Automatic Writing by Ataxia Ataxia is the brainchild of John Frusciante of the Red Hot Chili Peppers, Josh Klinghoffer of Bicycle Thief, and Joe Lally of Fugazi. This record is part of the Frusciante solo record series that'll continue to be released each month on vinyl and CD. |
 |
ATAXIA II by JOHN FRUSCIANTE |
 |
Ataxia II |
 |
My Thirty-Five Years with Ataxia by Patricia Birdsong Hamilton (Author) My name is Patricia Birdsong Hamilton. I was born and grew up in Atlanta, Georgia, graduated from Spelman College in Atlanta in 1974, and received my MBA from Atlanta University (now Clark - Atlanta University) in 1975. I am one of seven children born to Annie and R.C. Birdsong, am married and am the proud mother of one son and one daughter. I was diagnosed with Spinocerebellar Ataxia at the age of thirty-four. Because I was unable to find a book that could provide me with some insight into the way the disease may affect me, I decided to write my own. My objective was to learn how to live with my medical condition. The books I wrote are about my personal experiences before and after my diagnosis. I discovered ways to cope with the disease, the way I came to... |
 |
Automatic Writing Ataxia (Primary Contributor) |
 |
Ataxia by Circus Devils H.P. Lovecraft meets Devo on Ataxia, Circus Devils' new collection of moonshine revelries and musical trips by torchlight into the mist-shrouded fields and forests of Ohio (aka: land of mystery). Robert Pollard and the Tobias brothers treat the listener to an intoxicating blend of jagged, insistent rock and uneasy lullabies. |
|
|
AUTOMATIC WRITING by ATAXIA Ataxia is the brainchild of John Frusciante of the Red Hot Chili Peppers, Josh Klinghoffer of Bicycle Thief, and Joe Lally of Fugazi. This record is part of the Frusciante solo record series that'll continue to be released each month on vinyl and CD. |
 |
Handbook of Ataxia Disorders (Neurological Disease and Therapy) by Thomas Klockgether (Editor) Univ. of Bonn, Germany. Addresses basic and clinical science regarding the cerebellar disorders. For clinicians. Topics include: developmental disorders, autosomal recessive ataxias, mitochondrial disorders, autosomal dominant ataxias, transmissible spongiform encephalopathies, and more. |
 |
A Sphere in the Heart of Silence by John Frusciante, Josh Klinghoffer After strong international success with the first four releases of his six record series, the Red Hot Chili Peppers' guitarist now reveals his fifth album with longtime musical partner Josh Klinghoffer. Frusciante has been recording an album a month, spanning pop, experimental, electronic, and acoustic genres. Already released are "The Will To Death", Ataxia's "Automatic Writing", "DC EP", and "Inside Of Emptiness". |
 |
Smile from the Streets You Hold by John Frusciante Australian Version featuring Alternate Cover Art. Tracks Remain the Same as the Us Release. |
| © 2009 BrightSurf.com |